Clinically Important Drug Interactions with Disease-Modifying Antirheumatic Drugs

被引：0
作者：
Cees J. Haagsma
机构：
[1] Medisch Spectrum Twente,Department of Rheumatology
来源：
Drugs & Aging | 1998年 / 13卷
关键词：
Rheumatoid Arthritis; Methotrexate; Cyclosporin; Adis International Limited; Rheumatic Disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Rheumatic diseases are mostly chronic in nature and often require long term drug treatment. An increasing number of disease-modifying antirheumatic drugs (DMARDs) are used earlier in the course of disease and increasingly in combination with each other. Often there is comorbidity with ensuing pharmacotherapy, especially in the elderly, and therefore the risk of unwanted drug interactions increases. Awareness of these interactions is important in order to either avoid or manage them.
引用
收藏
页码：281 / 289
页数：8
相关论文
共 50 条
[21]   Safety of biological disease-modifying antirheumatic drugs in rheumatoid arthritis [J].
Martinez-Mugica, Cristina ;
Salgueiro, Esther .
FARMACIA HOSPITALARIA, 2022, 46 (01) :15-20
[22]   Perioperative management of disease-modifying antirheumatic drugs and other immunomodulators [J].
Moreira, P. M. ;
Correia, A. M. ;
Cerqueira, M. ;
Gil, M. F. .
ARP RHEUMATOLOGY, 2022, 1 (03) :218-224
[23]   Update on the use of conventional disease-modifying antirheumatic drugs in the management of rheumatoid arthritis [J].
Feely, Michael G. ;
O'Dell, James R. .
CURRENT OPINION IN RHEUMATOLOGY, 2010, 22 (03) :316-320
[24]   The Risk of Cardiovascular Events Associated With Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis [J].
Ozen, Gulsen ;
Pedro, Sofia ;
Michaud, Kaleb .
JOURNAL OF RHEUMATOLOGY, 2021, 48 (05) :648-655
[25]   Drug-Induced Gastrointestinal and Hepatic Disease Associated with Biologics and Nonbiologic Disease-Modifying Antirheumatic Drugs [J].
Wood, Patrick R. ;
Caplan, Liron .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2018, 44 (01) :29-+
[26]   The Relationship Between Autoimmune Disease and Disease-Modifying Antirheumatic Drugs on Wound Healing [J].
Kirloskar, Kunal M. ;
Dekker, Paige K. ;
Kiene, Julianne ;
Zhou, Suzanne ;
Bekeny, Jenna C. ;
Rogers, Ashley ;
Zolper, Elizabeth G. ;
Fan, Kenneth L. ;
Evans, Karen K. ;
Benedict, Carol Deane ;
Pasieka, Helena B. ;
Attinger, Christopher E. .
ADVANCES IN WOUND CARE, 2022, 11 (12) :650-656
[27]   Targets of biologic disease-modifying antirheumatic drugs and risk of multiple myeloma [J].
Calip, Gregory S. ;
Patel, Pritesh R. ;
Sweiss, Karen ;
Wu, Zhaoju ;
Zhou, Jifang ;
Asfaw, Alemseged A. ;
Adimadhyam, Sruthi ;
Lee, Todd A. ;
Chiu, Brian C-H .
INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (05) :1300-1305
[28]   Are biologics more effective than classical disease-modifying antirheumatic drugs? [J].
Michael T Nurmohamed ;
Ben AC Dijkmans .
Arthritis Research & Therapy, 10
[29]   Combination of methotrexate with oral disease-modifying antirheumatic drugs in psoriatic arthritis: a systematic review [J].
Hsieh, Tyng-Shiuan ;
Tsai, Tsen-Fang .
IMMUNOTHERAPY, 2024, 16 (02) :115-130
[30]   Evaluation of Access Disparities to Biologic Disease-Modifying Antirheumatic Drugs in Rural and Urban Communities [J].
Peterman, Nicholas J. ;
Vashi, Aksal ;
Govan, Devan ;
Bhatia, Amrit ;
Vashi, Tejal ;
Kaptur, Brad ;
Yeo, Eunhae G. ;
Gizinski, Alison .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
12345